A Clinical Study of AK0610

NCT06996704 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Study

Interventions

DRUG: AK0610 Injection solution
DRUG: Placebo

Sponsor

Shanghai Ark Biopharmaceutical Co., Ltd.